Cargando…

Fractionated stereotactic radiotherapy in the treatment of pituitary macroadenomas

BACKGROUND: The use of fractionated stereotactic radiotherapy (fsrt) has evolved with technical advances in noninvasive immobilization, radiation delivery, and image guidance. The application of fsrt to pituitary tumours is aimed at reducing toxicity through improved dose conformality and reduced tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elhateer, H., Muanza, T., Roberge, D., Ruo, R., Eldebawy, E., Lambert, C., Patrocinio, H., Shenouda, G., Souhami, L.
Formato:	Texto
Lenguaje:	English
Publicado:	Multimed Inc. 2008
Materias:	Radiation Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2601024/ https://www.ncbi.nlm.nih.gov/pubmed/19079630

Ejemplares similares

Adjuvant or radical fractionated stereotactic radiotherapy for patients with pituitary functional and nonfunctional macroadenoma
por: Weber, Damien C, et al.
Publicado: (2011)

Results of Treatment with Modern Fractionated Radiotherapy, Contemporary Stereotactic Radiosurgery, and Transsphenoidal Surgery in Nonfunctioning Pituitary Macroadenoma
por: Hsiao, Ping-Kun, et al.
Publicado: (2019)

The Quest for Optimal Fractionation Schedules in Stereotactic Radiotherapy
por: Shibamoto, Yuta, et al.
Publicado: (2020)

Toxicity Profiles of Fractionated Radiotherapy, Contemporary Stereotactic Radiosurgery, and Transsphenoidal Surgery in Nonfunctioning Pituitary Macroadenomas
por: Chang, Chia-Lun, et al.
Publicado: (2019)

Stereotactic Ablative Radiotherapy Fractionation for Hepatocellular Carcinoma in the United States
por: Sheth, Niki, et al.
Publicado: (2020)

Stereotactic Radiotherapy with Fractionation for the Lesions in and Around the Brainstem and Optic Nerve
por: Kida, Yoshihisa, et al.
Publicado: (2019)

Fractionated stereotactic radiotherapy for pediatric patients with retinoblastoma
por: Higgins, Patrick D., et al.
Publicado: (2006)

Deferred Radiotherapy After Debulking of Non-functioning Pituitary Macroadenomas: Clinical Outcomes
por: Nicholas, Sarah E., et al.
Publicado: (2019)

Stereotactic Body Radiotherapy for Inoperable Liver Tumors: Results of a Single Institutional Experience
por: Hijazi, Hussam, et al.
Publicado: (2016)

Does Combined Fractionated Stereotactic Radiotherapy and Immunotherapy Change the Outcome of Recurrent High-Grade Gliomas?
por: Yuce Sari, Sezin, et al.
Publicado: (2021)

Stereotactic Body Radiotherapy as an Effective Treatment for Pancreatic Cancer
por: Hurmuz, Pervin, et al.
Publicado: (2023)

Extracranial doses in stereotactic and conventional radiotherapy for pituitary adenomas
por: Ram, Thomas Samuel, et al.
Publicado: (2006)

Technique for Robotic Stereotactic Irradiation of Choroidal Melanoma
por: Béliveau-Nadeau, Dominic, et al.
Publicado: (2016)

RONC-06. Stereotactic radiosurgery and stereotactic radiotherapy for pediatric brain metastases or recurrences
por: McGovern, Susan, et al.
Publicado: (2022)

A Treatment Planning Study of Stereotactic Body Radiotherapy for Atrial Fibrillation
por: Xia, Ping, et al.
Publicado: (2016)

Stereotactic Radiotherapy for Intramedullary Spinal Arteriovenous Malformations
por: Mori, Yoshimasa, et al.
Publicado: (2018)

Implementation of Single-Fraction Lung Stereotactic Ablative Radiotherapy in a Multicenter Provincial Cancer Program During the COVID-19 Pandemic
por: Mou, Benjamin, et al.
Publicado: (2021)

Dosimetric consequences of rotational setup errors with direct simulation in a treatment planning system for fractionated stereotactic radiotherapy
por: Peng, Jean L., et al.
Publicado: (2011)

Assessing the Need for Adjuvant Chemotherapy After Stereotactic Body Radiation Therapy in Early-stage Non-small Cell Lung Carcinoma
por: Jumeau, Raphaël, et al.
Publicado: (2016)

A Phase II Multi-institutional Clinical Trial Assessing Fractionated Simultaneous In-Field Boost Radiotherapy for Brain Oligometastases
por: Rodrigues, George, et al.
Publicado: (2019)

Multiple Primary Lung Cancers: Treatment Outcomes After Stereotactic Body Radiotherapy (SBRT)
por: Choi, Gyujae, et al.
Publicado: (2023)

Radiomics Approach for Prediction of Recurrence in Non-Functioning Pituitary Macroadenomas
por: Zhang, Yang, et al.
Publicado: (2020)

Thymic Carcinoma Treated by CyberKnife Stereotactic Body Radiotherapy
por: Harada, Yuko, et al.
Publicado: (2017)

Stereotactic Radiotherapy for Pancreatic Cancer: A Single-Institution Experience
por: Glicksman, Rachel M, et al.
Publicado: (2020)

Diagnostic value of magnetic resonance imaging ectopic posterior pituitary hyperintense signal in pituitary macroadenoma
por: Luo, Yi-Lin, et al.
Publicado: (2022)

Transperineal ultrasound is a good alternative for intra‐fraction motion monitoring for prostate stereotactic body radiotherapy
por: Guo, Bingqi, et al.
Publicado: (2023)

Spine Stereotactic Body Radiotherapy Outcomes in Patients with Concurrent Brain Metastases
por: Colaco, Rovel J, et al.
Publicado: (2016)

RONC-20. RECURRENT HIGH-GRADE ASTROBLASTOMA TREATED WITH STEREOTACTIC RADIOTHERAPY
por: Nishimoto, Shota, et al.
Publicado: (2020)

Improving accuracy for stereotactic body radiotherapy treatments of spinal metastases
por: Rijken, James, et al.
Publicado: (2018)

Stereotactic Radiotherapy for Recurrent Post-Transplant Primary Central Nervous System Lymphoma
por: Benitez, Cecil M, et al.
Publicado: (2021)

Adjuvant Radiotherapy for Thymic Neuroendocrine Tumors: A Case Report and Review of the Literature
por: Iskanderani, Omar, et al.
Publicado: (2017)

Disparities in the Use of Single-fraction Stereotactic Radiosurgery for the Treatment of Brain Metastases From Non-small Cell Lung Cancer
por: Modh, Ankit, et al.
Publicado: (2019)

Development of an independent MU calculation software for radiotherapy treatments with stereotactic cones
por: Campos, Guilherme Filipe Pinto, et al.
Publicado: (2022)

Symptomatic Brain Radiation Necrosis in an Anaplastic Lymphoma Kinase (ALK)-Positive Non-small Cell Lung Cancer (NSCLC) Patient After Fractionated Stereotactic Radiotherapy While on Alectinib
por: BalajiSubramanian, Sitaraman, et al.
Publicado: (2023)

Comparative Study of Hypo-Fractionated Radiotherapy Versus Conventional Radiotherapy in Breast Cancer
por: Narwariya, Abhinav, et al.
Publicado: (2022)

Intractable Pleural Effusion After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer
por: Katano, Atsuto, et al.
Publicado: (2023)

Brachytherapy Versus Stereotactic Body Radiotherapy for Cervical Cancer Boost: A Dosimetric Comparison
por: Dahbi, Zineb, et al.
Publicado: (2023)

Effect of pituitary‐dependent hypercortisolism on the survival of dogs treated with radiotherapy for pituitary macroadenomas
por: Rapastella, Sofia, et al.
Publicado: (2023)

Clinical Outcomes of Spatially Fractionated GRID Radiotherapy in the Treatment of Bulky Tumors of the Head and Neck
por: Choi, J. Isabelle, et al.
Publicado: (2019)

Stereotactic Radiotherapy for Cervical Spinal Intramedullary Metastasis and Multiple Brain Metastases: A Case Report
por: Mori, Yoshimasa, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7ve6gg81cbndb25ctvgudhigvc